𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Predictors of patient preferences and treatment choices for localized prostate cancer

✍ Scribed by Benjamin D. Sommers; Clair J. Beard; Anthony V. D'Amico; Irving Kaplan; Jerome P. Richie; Richard J. Zeckhauser

Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
112 KB
Volume
113
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Decision analysis using individual patie
Decision analysis using individual patient preferences to determine optimal treatment for localized prostate cancer
✍ Benjamin D. Sommers; Clair J. Beard; Anthony V. D'Amico; Douglas Dahl; Irving Ka πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 130 KB

## Abstract ## BACKGROUND Selecting treatment for clinically localized prostate cancer remains an ongoing challenge. Previous decision analyses focused on a hypothetical patient with average preferences, but preferences differ for clinically similar patients, implying that their optimal therapies

Patient satisfaction with treatment deci
Patient satisfaction with treatment decisions for clinically localized prostate carcinoma. Results from the Prostate Cancer Outcomes Study
✍ Richard M. Hoffman; William C. Hunt; Frank D. Gilliland; Robert A. Stephenson; A πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 93 KB πŸ‘ 1 views

## Abstract ## BACKGROUND Men with early‐stage prostate carcinoma can choose aggressive treatment or conservative management. The authors used data from a population‐based cohort of men with clinically localized prostate carcinoma to describe satisfaction with treatment decisions 24 months after d

Treatment β€˜mismatch’ in early prostate c
Treatment β€˜mismatch’ in early prostate cancer : Do treatment choices take patient quality of life into account?
✍ Ronald C. Chen; Jack A. Clark; Judith Manola; James A. Talcott πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 127 KB

## Abstract ## BACKGROUND. Pretreatment urinary, bowel, and sexual dysfunction may increase the toxicity of prostate cancer treatments or preclude potential benefits. Using patient‐reported baseline dysfunction from a prospective cohort study, we determined the proportion of patients receiving rel

Primary treatment choices for men with c
Primary treatment choices for men with clinically localized prostate carcinoma detected by screening
✍ Yan Yan; Gustavo F. Carvalhal; William J. Catalona; James D. Young πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 89 KB πŸ‘ 2 views

## Background: Increasingly, prostate carcinoma is diagnosed through screening. however, little is known regarding factors that influence a patient's decision concerning the treatment choices presented to him. ## Methods: Subjects were prostate carcinoma patients detected through the washington u